CC
Commodore Capital Portfolio holdings
AUM
$1.42B
1-Year Est. Return
73.3%
1 Year Est. Return
+73.3%
AUM
$1.36B
AUM Growth
-$7.47M
(-0.55%)
Holding
35
Top Buys
| 1 | +$64M | |
| 2 | +$58.1M | |
| 3 | +$25.6M | |
| 4 |
Merus
MRUS
|
+$25.2M |
| 5 |
Solid Biosciences
SLDB
|
+$21.6M |
Top Sells
| 1 | +$26.8M | |
| 2 | +$13.9M | |
| 3 | +$11.6M | |
| 4 |
ABVX
Abivax
ABVX
|
+$9.4M |
| 5 |
BBOT
BridgeBio Oncology
BBOT
|
+$5.25M |
Sector Composition
| 1 | Healthcare | 99.43% |
| 2 | Financials | 0.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Merus
MRUS
$7.16B
| $188M | 13.87% |
4,472,840
+598,658
|
|
||
2
Nuvalent
NUVL
$6.55B
| $132M | 9.69% |
1,855,000
+233,400
|
|
||
3
Enliven Therapeutics
ELVN
$1.22B
| $92M | 6.78% |
4,675,000
+470,000
|
|
||
4
Soleno Therapeutics
SLNO
$3.38B
| $82.2M | 6.05% |
1,150,000
-375,000
|
|
||
5
Xenon Pharmaceuticals
XENE
$3.18B
| $78M | 5.75% |
2,325,000
-415,000
|
|
||
6
Alkermes
ALKS
$4.96B
| $64.4M | 4.74% |
1,950,000
-350,000
|
|
||
7
Agios Pharmaceuticals
AGIO
$2.45B
| $64M | 4.72% |
+2,185,000
|
|
||
8
Vaxcyte
PCVX
$5.4B
| $62.3M | 4.59% |
1,650,000
+25,000
|
|
||
9
Vera Therapeutics
VERA
$1.8B
| $61.5M | 4.53% |
2,561,782
+603,182
|
|
||
10
Celldex Therapeutics
CLDX
$1.74B
| $58.1M | 4.28% |
+3,200,000
|
|
||
11
Scholar Rock
SRRK
$2.76B
| $56.1M | 4.13% |
1,745,000
+795,000
|
|
||
12
Cogent Biosciences
COGT
$2.07B
| $53.3M | 3.93% |
8,892,816
+2,011,187
|
|
||
13
Viridian Therapeutics
VRDN
$1.8B
| $48.5M | 3.58% |
3,600,000
+1,200,000
|
|
||
14
Nurix Therapeutics
NRIX
$800M
| $47.3M | 3.48% |
3,978,907
+978,907
|
|
||
|
CNTA
15
Centessa Pharmaceuticals
CNTA
$3.24B
| $34M | 2.51% |
2,367,578
+149,153
|
|
||
16
Spyre Therapeutics
SYRE
$1.73B
| $32.1M | 2.36% |
1,988,084
|
|
||
17
Pharvaris
PHVS
$1.48B
| $30M | 2.21% |
1,911,433
|
|
||
18
MindMed
MNMD
$949M
| $26.5M | 1.95% |
4,525,000
+216,575
|
|
||
|
19
Solid Biosciences
SLDB
$430M
| $21.6M | 1.59% |
+5,825,000
|
|
||
|
DRUG
20
Bright Minds Biosciences
DRUG
$436M
| $18M | 1.33% |
500,000
|
|
||
21
Cardiff Oncology
CRDF
$147M
| $16.9M | 1.25% |
5,384,616
|
|
||
|
ORKA
22
Oruka Therapeutics
ORKA
$1.31B
| $14.6M | 1.07% |
1,419,714
|
|
||
23
Inhibikase Therapeutics
IKT
$114M
| $11.7M | 0.86% |
5,344,432
-580,568
|
|
||
24
Oric Pharmaceuticals
ORIC
$1.21B
| $11.2M | 0.82% |
2,000,000
|
|
||
25
Apogee Therapeutics
APGE
$3.64B
| $10.8M | 0.8% |
290,000
|
|